4.5 Article

Effects of parathyroidectomy on plasma PTH fragments and heart rate variability in stage 5 chronic kidney disease patients

期刊

RENAL FAILURE
卷 43, 期 1, 页码 890-899

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1080/0886022X.2021.1931318

关键词

Chronic kidney disease; (1-84) PTH; (7-84) PTH; heart rate variability; secondary hyperparathyroidism; parathyroidectomy

资金

  1. National Natural Science Foundation of China [81270408, 81570666]
  2. International Society of Nephrology (ISN) Clinical Research Program [1801-0247]
  3. Construction Program of Jiangsu Provincial Clinical Research Center Support System [BL2014084]
  4. Chinese Society of Nephrology [13030300415]
  5. Jiangsu Province Key Medical Personnel Project [RC201162, ZDRCA2016002]
  6. CKD Anemia Research Foundation from China International Medical Foundation [Z-2017-24-2037]
  7. Outstanding Young and Middle-aged Talents Support Program of the First Affiliated Hospital of Nanjing Medical University (Jiangsu Province Hospital)

向作者/读者索取更多资源

This study found correlations between plasma (1-84) PTH levels and heart rate variability (HRV) in CKD5 patients, with improved HRV related to decreased levels of (1-84) PTH and (7-84) PTH after PTX. No antagonistic effects of (1-84) PTH and (7-84) PTH on HRV were observed in CKD5 patients.
Introduction Circulating intact parathyroid hormone (iPTH) levels include full-length (1-84) PTH and long C-PTH fragments, but primarily (7-84) PTH, which have been reported to have antagonistic effects on the bones and kidneys. However, their effects on the cardiovascular system remain unclear. In this study, the relationships between the plasma PTH fragments levels and heart rate variability (HRV) in stage 5 chronic kidney disease (CKD5) patients are explored. Furthermore, the effects of parathyroidectomy (PTX) on the above indices are investigated. Methods In this cross-sectional study, 164 healthy controls and 354 CKD5 patients, including 208 secondary hyperparathyroidism (SHPT) subgroup with PTX, were enrolled. Circulating (7-84) PTH levels were calculated by subtracting plasma (1-84) PTH levels from iPTH levels. The HRV parameters were measured using a 24-hour Holter. Results The baseline levels of plasma iPTH, (1-84) PTH, and (7-84) PTH in the CKD5 patients were 930.40 (160.65, 1792.50) pg/mL, 448.60 (99.62, 850.45) pg/mL, and 468.20 (54.22, 922.55) pg/mL, respectively. In the CKD5 patients, plasma (1-84) PTH levels were independently correlated with the standard deviation of the normal-to-normal R-R intervals (SDNN) and the standard deviation of the five-minute average of the normal R-R intervals (SDANN). With a median follow up time of 6.50 months after PTX in the SHPT patients (n = 30), improved SDNN and SDANN markers were related with decreased (1-84) PTH levels. Furthermore, an improved SDNN was related with decreased (7-84) PTH levels. Conclusions The CKD5 patients' baseline (1-84) PTH levels were correlated with the SDNN and SDANN. After PTX, an improved SDNN was related with decreased (1-84) PTH and (7-84) PTH levels, while improved SDANN was related with decreased (1-84) PTH levels. No antagonistic effects of (1-84) PTH and (7-84) PTH on HRV were found in the CKD5 patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据